Susquehanna International Group’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $271K | Sell |
|
|||||
|
2024
Q4 | $550K | Buy |
|
|||||
|
2024
Q3 | $165K | Sell |
|
|||||
|
2024
Q2 | $278K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $539K | Buy |
|
|||||
|
2023
Q3 | $399K | Sell |
|
|||||
|
2023
Q2 | $509K | Buy |
|
|||||
|
2023
Q1 | $176K | Sell |
|
|||||
|
2022
Q4 | $510K | Sell |
|
|||||
|
2022
Q3 | $652K | Buy |
|
|||||
|
2022
Q2 | $199K | Buy |
|
|||||
|
2022
Q1 | $184K | Sell |
|
|||||
|
2021
Q4 | $490K | Buy |
|
|||||
|
2021
Q3 | $299K | Sell |
|
|||||
|
2021
Q2 | $817K | Buy |
|
|||||
|
2021
Q1 | $319K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $892K | Buy |
|
|||||
|
2020
Q2 | $222K | Sell |
|
|||||
|
2020
Q1 | $814K | Sell |
|
|||||
|
2019
Q4 | $1M | Buy |
|
|||||
|
2019
Q3 | $550K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $377K | Sell |
|
|||||
|
2018
Q4 | $1.17M | Buy |
|
|||||
|
2018
Q3 | $1.04M | Buy |
|
|||||
|
2018
Q2 | $768K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $239K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $1.25M | Buy |
|
|||||
|
2016
Q2 | $745K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $693K | Buy |
|